Acute stress reaction
Conditions
Interventions
Sponsors
Universidade Federal de Alfenas
Universidade Federal de Alfenas
Eligibility
Age
20 Years to 50 Years
Inclusion criteria
Inclusion criteria: Individuals diagnosed with stress; Lipp Adult Stress Symptom Inventory (ISSL) score greater than 4; cognitive ability to read and interpret the purpose of the research and answer the assessment instruments; and acknowledgment and approval of the informed consent form; male or female volunteers aged between 20 and 50 years
Exclusion criteria
Exclusion criteria: Smokers; with a history of dizziness or seizure; pregnancy; signs of severity and/or indications for hospitalization or psychotherapy; use of anxiolytics; use of antidepressants; adverse effects detected in the group treated with tDCS and taVNS, including itching, tingling, headache, burning sensation and discomfort; diagnosis of depression; anxiety diagnosis; mood disorder bipolar with depressive, manic or hypomanic symptoms in the last year; schizophrenia or other psychotic disorders; autism; dependency of substances; diagnosis of epilepsy or use of anticonvulsants; contraindications for TDCS (metallic implants, tumor, brain surgeries previous, important cranioencephalic anatomical alteration); contraindications for non-invasive vagus nerve stimulation (cochlear implant, ear plastic surgery, ear malformation); starting and/or changing the dose of psychopharmaceuticals in the last three months
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Expected outcome 1: It is expected to find a reduction in symptom intensity, perception of stress, and improvement in sleep after the treatment period and one month after the end of the interventions. This will be verified through the reduction of the score on the Lipp's Adult Stress Symptom Inventory (ISSL), the Perceived Stress Scale (PSS-10), and the Pittsburgh Sleep Quality Index (PSQI), respectively. This is based on observing a variation of at least 5% in the pre, post-intervention, and one-month follow-up measurements.;Outcome found 1: A reduction in symptom intensity and perception of stress, as well as an improvement in sleep, was observed after the treatment period and one month after the end of the interventions. This was verified by the reduction of the score on Lipp's Adult Stress Symptom Inventory (ISSL), the Perceived Stress Scale (PSS-10), and the increase in the Pittsburgh Sleep Quality Index (PSQI), respectively. This is based on observing a variation of at least 5% in the pre, post-intervention, and one-month follow-up measurements | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary outcomes were not expected. | — |
Countries
Brazil
Contacts
Public ContactMarcelo Silva
Universidade Federal de Alfenas
Outcome results
None listed